SARILUMAB

Clinical Indication

Moderate to Severe Rheumatoid Arthritis

Comments

In line with NICE TA 485

Date of classification

January 2018

Review date

January 2020

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).